InterCure Ltd. (TLV:INCR)

Market Cap	247.60M
Revenue (ttm)	243.12M
Net Income (ttm)	-70.93M
Shares Out	54.51M
EPS (ttm)	-1.41
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	85,473
Average Volume	86,314
Open	448.50
Previous Close	448.50
Day's Range	440.60 - 460.00
52-Week Range	431.00 - 670.00
Beta	0.58
RSI	33.97
Earnings Date	Dec 1, 2025

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 320
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: INCR

Financial Performance

In 2024, InterCure's revenue was 238.85 million, a decrease of -32.82% compared to the previous year's 355.55 million. Losses were -67.80 million, 9.42% more than in 2023.